Testing effectiveness (Phase 2)UnknownNCT06334367What this trial is testingProphylaxis of Graft-versus-host Disease With Anti-CD25 Antibody in Patients Underwent HSCTWho this might be right forGVHD Wang Xin 40
Testing effectiveness (Phase 2)Study completedNCT00054600What this trial is testingSafety and Efficacy Study of Photopheresis With UVADEX to Prevent Graft-versus-Host DiseaseWho this might be right forGraft-versus-Host Disease Mallinckrodt 60
Large-scale testing (Phase 3)UnknownNCT01526850What this trial is testingEfficacy and Safety Study of Allogenic Mesenchymal Stem Cells for Patients With Chronic Graft Versus Host DiseaseWho this might be right forChronic Graft Versus Host Disease Chinese Academy of Medical Sciences 100
Not applicableLooking for participantsNCT07535008What this trial is testingDental Cleaning to Prevent Chronic Graft-Versus-Host DiseaseWho this might be right forChronic Graft Versus Host DiseaseAcute Graft Versus Host DiseaseHematopoietic and Lymphatic System Neoplasm Fred Hutchinson Cancer Center 45
Testing effectiveness (Phase 2)Study completedNCT04112810What this trial is testingTildrakizumab for Prevention of Acute Graft-Versus-Host DiseaseWho this might be right forHematologic Malignancies Medical College of Wisconsin 51
Testing effectiveness (Phase 2)Looking for participantsNCT07011810What this trial is testingAxatilimab for Sclerotic Chronic Graft-versus-Host DiseaseWho this might be right forChronic Graft Versus Host Disease Fred Hutchinson Cancer Center 50
Not applicableLooking for participantsNCT00001529What this trial is testingImproved Methods of Cell Selection for Bone Marrow Transplant AlternativesWho this might be right forGraft-Versus-Host DiseaseGraft-versus-leukemiaDonor Apheresis National Heart, Lung, and Blood Institute (NHLBI) 500
Not applicableStudy completedNCT02483702What this trial is testingIrradiated Blood Versus Non Irradiated Blood Transfusions in Craniosynostosis RepairWho this might be right forGraft Versus Host DiseaseHyperkalemiaCraniectomy+3 more Valley Anesthesiology Consultants 20
Testing effectiveness (Phase 2)Study completedNCT00810602What this trial is testingVorinostat to Prevent Graft Versus Host Disease Following Reduced Intensity, Related Donor Stem Cell TransplantWho this might be right forHematologic MalignanciesGraft vs Host Disease Pavan Reddy, MD 61
Testing effectiveness (Phase 2)Study completedNCT00096096What this trial is testingTacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell TransplantationWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more Fred Hutchinson Cancer Center
Not applicableNo Longer AvailableNCT00826046What this trial is testingProchymal® Expanded Access for Adults Who Have Failed Steroid Treatment for Acute Graft Versus Host Disease (GVHD)Who this might be right forGraft-Versus-Host Disease Mesoblast, Inc.
Early research (Phase 1)Not Yet RecruitingNCT07350057What this trial is testingA Preliminary Clinical Study on the Efficacy of Cyclophosphamide and Sirolimus Combined With VIC-1911 in Preventing Graft-versus-Host Disease After Haploidentical Stem Cell Transplantation in ChildrenWho this might be right forGVHD (Acute or Chronic) Shanghai Jiao Tong University School of Medicine 9
Early research (Phase 1)Ended earlyNCT00725062What this trial is testingDonor T Cells in Treating Patients With High-Risk Hematologic Cancer Undergoing Donor Peripheral Blood Stem Cell TransplantWho this might be right forGraft Versus Host DiseaseLeukemiaLymphoma+2 more Masonic Cancer Center, University of Minnesota 3
Testing effectiveness (Phase 2)Study completedNCT02806375What this trial is testingPTCy and Ruxolitinib GVHD Prophylaxis in MyelofibrosisWho this might be right forPrimary MyelofibrosisMyeloproliferative Disorders St. Petersburg State Pavlov Medical University 20
Testing effectiveness (Phase 2)Ended earlyNCT02461134What this trial is testingClinical Study to Investigate the Biological Activity, Safety, Tolerability, and Pharmacokinetics of Ponesimod in Subjects With Symptomatic Chronic GVHDWho this might be right forChronic Graft Versus Host Disease Actelion 1
Early research (Phase 1)Ended earlyNCT04070781What this trial is testingItacitinib and Tocilizumab for Steroid Refractory Acute Graft Versus Host DiseaseWho this might be right forSteroid Refractory GVHDGraft Vs Host Disease Columbia University 1
Early research (Phase 1)Study completedNCT00001830What this trial is testingDonor Th2 Cells to Prevent Graft-Versus-Host Disease in Bone Marrow TransplantsWho this might be right forChronic Lymphocytic LeukemiaGraft vs Host DiseaseHodgkin's Disease+2 more National Cancer Institute (NCI) 110
Large-scale testing (Phase 3)Study completedNCT02652130What this trial is testingSafety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHDWho this might be right forGrade B Acute Graft Versus Host DiseaseGrade C Acute Graft Versus Host DiseaseGrade D Acute Graft Versus Host Disease Mesoblast, Inc. 32
Testing effectiveness (Phase 2)Study completedNCT01701245What this trial is testingPrevention and Acute Treatment of Chronic Cluster Headache Compared to Standard of CareWho this might be right forChronic Cluster Headache ElectroCore INC 97
Testing effectiveness (Phase 2)Study completedNCT00201799What this trial is testingInfliximab for the Prevention of Graft-versus-Host Disease Following Allogenic Hematopoietic Stem Cell TransplantationWho this might be right forGraft-Versus-Host Disease Ohio State University Comprehensive Cancer Center 19